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Abstract: Obtaining sufficient contrast is an indispensable requirement for 
detecting early stage cancer using optical coherence tomography (OCT), an 
emerging  diagnostic  tool  that  detects  abnormal  lesions  with  micrometer 
resolutions in real time. PEGylated gold nanoparticles (Au NPs; 87 nm in 
diameter) were formulated in aqueous dissolvable microneedles (dMNs; 200 
µm height) for efficient, precisely controlled, and convenient delivery of Au 
NPs into hamster oral tissue in vivo. The Au NPs were then further briefly 
dissipated by ultrasound (US). The results showed 33% and 20% increase in 
average optical scattering intensity (contrast level) in dysplastic and normal 
tissues, respectively, and pinpointed pathological structures of early stage 
oral  cancer  were  also  identified  by  the  highly  convenient  and  efficient 
administration of Au NPs in a novel delivery platform. 
©2010 Optical Society of America 
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1. Introduction 
Optical  coherence  tomography  (OCT)  is  a  non-invasive  (or  minimally  invasive)  optical 
imaging tool that detects scattering signals from tissues irradiated with near-infrared (NIR) 
laser light [1]. OCT is capable of a real time “optical biopsy”, visualizing the morphology of a 
target tissue  with  micrometer resolution in real time [2,3],  with  many important potential 
applications, such as diagnosing early stage carcinoma within the OCT’s imaging depth of a 
few mm [4,5]. However, the use of high-resolution OCT for diagnosis of early stage cancer is 
still limited because of the difficulty in obtaining sufficiently high optical contrast in deep 
tissue by overcoming multiple photon scattering [6–9]. Various NIR dyes (e.g., indocyanine 
green, ICG) and micro- and nanoparticles have been explored as OCT contrast agents [10]. 
Despite  the  great  interest  in  employing  gold  nanoparticles  (Au  NPs)  by  using  their  high 
biocompatibility and superior optical properties, efficient delivery of Au NPs to specific target 
tissues has been a major hurdle [10,11]. Recently, we reported significantly enhanced OCT 
imaging of early stage oral cancer via a multimodal Au NP delivery method by combining 
tissue  penetration  by  Au  NPs  using  microneedles  (MNs)  with  Au  NP  dissipation  using 
ultrasound  (US)  [6].  However,  topical  delivery  of  an  Au  NP-containing  solution  onto 
microchannels produced by the use of a stainless steel MN roller is not an ideal mode of 
administration.  First,  a  majority  of  Au  NPs  simply  remain  deposited  on  the  outer  tissue 
surface  (e.g.,  stratum  corneum,  SC)  instead  of  being  delivered  through  the  MN-created 
passages (poor efficiency). Second, it is almost impossible to predict/quantify the amount of 
Au NPs delivered into the tissue (unrepeatable dose control). Finally, the use of a stainless 
steel MN roller followed by topical application of Au NP-containing solution on the MN-
applied  area,  then  wiping  deposited  Au  NPs  into  the  tissue  surface,  is  inconvenient  and 
imprecise. 
In this study, Au NPs were formulated into dissolvable microneedles (dMNs) in order to 
overcome  the  limitations  mentioned  above.  Au  NPs  (87  nm  in  diameter)  were  mixed  in 
sodium carboxymethyl cellulose (SCMC) solution. Then the mixture was cast into an array of 
needle-shaped  holes  by  centrifugation  and  air-dried  in  order  to  obtain  Au  NP-containing 
dMNs. Advantages of this approach include: (1) Au NPs are concentrated at the tips of dMNs 
to maximize NP delivery into target tissue; (2) Penetration depth of Au NPs (locations of Au 
NPs)  can  be  easily  controlled  by  the  length  of  dMNs,(3)  Au  NPs  can  be  conveniently 
administered simply by applying dMNs (no separate steps of MN application, dropping Au 
NP-containing solution, and wiping surface-deposited Au NPs); (4) dMNs are biocompatible 
and do not need to be removed after use. 
The hamster cheek pouch carcinogenesis model was used to generate oral dysplasia in 
order to investigate in vivo contrast-enhanced OCT imaging using Au NP-containing dMNs. 
Using a spectral domain OCT (SD-OCT) system, significantly increased average scattering 
signals were confirmed in dysplastic and normal tissues using the proposed approach, and 
more  importantly,  abnormal  structures  in  dysplastic  tissues  were  clearly  distinguished  by 
OCT. Therefore, dMNs provide a promising and novel device platform for contrast-enhanced 
OCT imaging via multimodal administration of Au NPs. 
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2.1 Synthesis of Au NPs 
Scattering dominant, citrate capped Au NPs (70 nm in diameter) were synthesized by Frens’ 
method [12] with a slight modification as reported previously [6]. The size of resulting Au 
NPs was measured by using dynamic light scattering (DLS) particle analysis using a Melvern 
Zetasizer as well as transmission electron microscopy (TEM). The final Au NP concentration 
was determined to be 6.94 × 10
9 particles/mL by UV/vis spectroscopy [13]. The surface of Au 
NPs  were  PEGylated  by  activating  the  surface  with  N  -succinimidyl  3-(2-pyridyldithio)-
propionate  (SPDP)  and  reacting  with  amine-activated  polyethylene  glycol  (PEG;  2  kDa). 
Briefly, Au NPs were washed with DI water by centrifugation at 4,600 rpm for 10 min three 
times. Sixty mL of Au NPs were gradually added to vigorously stirred 12 µL of 20 mM SPDP 
on ice using a peristatic pump at 7 µL/s flow rate. The mixture remained stirred in room 
temperature overnight. After unreacted SPDP was removed by centrifugation at 4,600 rpm for 
10 min three times, 60 mL of SPDP-activated Au NPs were added to 45.6 µL of amine-PEG 
(10 mg/mL) with vigorous stirring, followed by incubation at room temperature overnight. 
Unreacted amine-PEG was removed by centrifugation three times at 4,600 rpm for 30 min. 
The size of the PEGylated Au NPs was determined to be 87 nm in diameter by DLS at the 
final concentration of 6.41 × 10
8 particles/mL. 
2.2 Fabrication of Au NP-containing dissolvable microneedles 
Briefly, a metal pyramid-shape MN array was fabricated by precision machining to obtain a 
sharp tip apex of 10-20 µm radius. The length of the pyramid needles was 200 µm with the 
height to base ratio of 2.3. The density of needles in the area was 400/cm
2. A silicone mold 
was cast from the metal needle array and used to produce dissolvable Au NP MNs. Sodium 
carboxylmethyl cellulose (SCMC, 90kDa) (Sigma, St. Louis, MO) that is relatively highly 
aqueous soluble and mechanically robust in a dry form was mixed with sucrose (Hercules 
Inc., Wilmington, DE) at a 1:3.75 weight ratio (SCMC:sucrose) to accelerate dissolution in 
tissue. Au NP-containing solution (200 µL, Au NP concentration: 1.92 × 10
10 particles/mL) 
was mixed with the SCMC-sucrose solution (100 µL of 8% SCMC and 30% sucrose). To 
fabricate the Au NP-concentrated tip needles, the Au NP-containing SCMC-sucrose solution 
was  spun  on  the  mold  at  4,000  rpm  for  5  minutes  to  fill  the  needle-shaped  cavities  and 
concentrate Au NPs at the cavity end, immediately followed by removal of residual excess 
from the exterior of the needle-shaped cavities. In the second coating, the Au NP-free solution 
was added onto the mold to form a MN-immobilizing disc layer. After air-drying for 24 h, Au 
NP-containing  dMNs  on  a  1  cm  disc  were  obtained  (Fig.  1).  When  the  SCMC-sucrose 
solution  was  dried  in  the  mold,  its  volume  shrank  by  80%  towards  the  cavity  end,  thus 
retaining Au NP at the end of the microneedle structures. 
 
Fig. 1. Au NP-containing dissolvable microneedles (dMNs) arrayed on a dissolvable disc (1 cm 
in diameter). 
2.3 In vivo hamster oral cancer model and histology 
Golden Syrian hamsters (Mesocricetus auratus) were topically treated with 0.5% (w/v) 9, 10-
dimethyl-1,2-benzanthracene (DMBA, Sigma) in mineral oil three times per week for 10 wks 
to induce dysplasia in one cheek pouch in each animal (in accordance  with UCI IACUC 
protocol approval 97-1972). The other contralateral cheek pouch remained untreated. Imaging 
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to a microscope stage using a custom-built, ring-shaped clamp (Fig. 2). The ring was used to 
ensure accurate co-localization of subsequent imaging episodes. After Au NP administration 
by combined dMN and US, DMBA-treated and untreated hamster cheek pouch tissues were 
harvested  and  fixed  for  a  day  in  10%  formalin  buffer  followed  by  transfer  to  phosphate 
buffered  saline  (PBS)  solution.  The  paraffin-embedded  tissues  were  sectioned  at  6  µm 
thickness for a hematoxylin and eosin (H&E) staining. The stained tissues were visualized 
under a microscope equipped with an Olympus Microfire digital camera (Olympus, Tokyo, 
Japan). 
 
Fig. 2. DMBA-treated hamster cheek pouch attached to a microscope stage using a custom-
built, ring-shaped clamp (1 cm in diameter). 
2.4 OCT imaging and signal quantification 
A SD-OCT system (Fig. 3) was used to obtain OCT images from the hamster cheek pouch 
tissues. Specifications of the SD-OCT system include low-coherence light with 1310 nm of 
center wavelength and 90 nm of full width at half maximum (FWHM), a 1 × 1024 InGaAs 
detector array at 7.7 kHz frame rate with a 130 nm wide spectrum, and a 2-axis scanner with 
two galvanometers located at the same sample arm. Imaging depth and depth resolution were 
3.4 mm and 8 µm in air, respectively, and SD-OCT images were obtained at the same focal 
point throughout the study. 
 
Fig. 3. Schematic of optical fiber-based spectral-domain (SD)-OCT system: AL, aiming laser; 
CM, collimator; DAQ, data acquisition system; DG, diffraction grating; FL, focusing lens; 
LCL, low-coherence light; LSC, line scan camera. 
Hamster cheek pouches were imaged before and after dMNs were administered and US 
was applied. Briefly, dMNs placed in the clamp’s circular hole were pressed with a finger for 
10 min. After applying US gel, a diagnostic level US force (1 MHz at 0.3 W/cm
2 power 
density) was applied using a Dynatron 125 ultrasonicator (Dynatronics Corporation, Salt Lake 
City, UT) for 1 min. The tissues were imaged using a SD-OCT at various time points up to 30 
min. The area of interest (210 pixels long × 5 pixels wide) in the acquired OCT images was 
analyzed for OCT signal intensity using Scion image processing software, and the signals in 
three different areas were averaged for statistical significance. 
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A major hurdle to the topical delivery of Au NPs is the stratum corneum (10-40 µm). The 
optimal penetration depth for diagnostic OCT imaging in the epithelial layer is in the range of 
50-400 µm. Microscopy confirmed that Au NP-containing dMNs (Fig. 4a) had a height of 200 
µm and ~85 µm base in a semi-transparent, sharp pyramid shape. Most noticeably, Au NPs 
had  indeed  been  highly  concentrated  by  centrifugation,  forming  a  dark  tip  on  each  MN  
(Fig. 4a). The OCT image in Fig. 4b shows that a dMN was able to penetrate into the hamster 
cheek pouch tissue. The concave injection site caused by the dMN-pressing force indicates 
that Au NPs can be delivered at a depth of 100-200 µm, which meets the required penetration 
depth. 
 
Fig. 4. Au NPs containing dissolvable microneedles (200 µm height). 
OCT signals (scattering intensity) from normal and dysplastic tissues, before and after 
dMN application with US, were quantified (Fig. 5). The average OCT signal intensity from 
normal  base  tissue  (i.e.,  without  dMN  and  US  application)  was  higher  than  that  from 
dysplastic  tissue,  possibly  because  the  process  of  carcinogenesis  using  the  hamster  cheek 
pouch  model  causes  localized  areas  of  epithelial  thickening  and  increased  keratinization 
which inhibit light penetration. Interestingly, however, once the dMN and US were applied, 
the  intensity  of  the  OCT  signal  increased  by  33%  in  dysplastic  tissue  while  only  a  20% 
increase in OCT signal intensity was observed in normal tissues. It has been reported that as 
dysplasia develops and progresses, the epithelium loses its functions as a biological barrier, 
permitting increased penetration of contrast agents (i.e., PEGylated Au NPs) into the tissues 
[14]. Therefore, the higher OCT signal increase after dMN and US application observed in 
dysplastic tissue (Fig. 5) might be attributed to the presence in the tissues of a high number of 
Au NPs as well as an enhanced surface plasmon resonance (SPR) effect from co-localized Au 
NPs due to their high density in dysplastic tissue. 
 
Fig. 5. Average SD-OCT signal (scattering intensity) from normal and dysplastic hamster oral 
tissues before and after dMN and US application. 
The pathological characteristics of dysplasia were further observed by OCT (Fig. 6) and 
quantitatively compared (Fig. 7). Structural differences between dysplastic vs. normal tissue 
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stratification was apparent as shown in Figs. 6c and 6d, respectively. Overall, optical contrast 
levels in the epithelial layer (green areas in Fig. 7) increased in dysplastic and normal tissues 
after dMNs and US had been applied. Analysis of quantitative depth-dependent distributions 
of OCT signal intensity (Fig. 7) indicates a couple of key differences between dysplastic and 
normal tissues, before and after dMN and US had been applied. First, the OCT signal intensity 
in the stratum corneum (SC, yellow areas in Fig. 7) increased in dysplastic tissue after dMNs 
and US had been applied (Fig. 7a) whereas signals did not change markedly in normal tissue 
(Fig. 7b). This is consistent with a previous finding that more Au NPs were accumulated in 
the SC of dysplastic tissue than normal tissue [6]. Second and most importantly, the signal 
intensity  profiles  in  the  normal  epithelial  layer  before  and  after  dMNs  and  US  had  been 
applied were fairly well-matched. In contrast, a dramatic optical contrast (blue area in Fig. 7) 
ensued  in  the  dysplastic  epithelial  layer  after  dMNs  and  US  had  been  applied.  For 
comparison, a very similar level of OCT signals was obtained in the dysplastic epithelial 
layer, regardless of depth, before dMNs and US had been applied (blue line in Fig. 7a). The 
results  shown  in  Figs.  6  and  7  demonstrate  that  clear  and  quantitative  imaging-based 
differences between dysplastic and normal tissues were obtained by administering Au NPs in 
dMNs in combination with a brief and mild US stimulation. It should be emphasized that the 
amount of Au NPs formulated in the dMNs used in this study was approximately 200 times 
less than what was used in a previous study utilizing stainless steel MNs pre-treatment, topical 
application  of  Au  NP-containing  solutions,  wiping  of  surface-deposited  Au  NPs,  and  US 
application. Therefore, dMNs are a highly convenient, precisely dose-controllable, and an 
efficient platform to deliver Au NPs for contrast-enhanced detection of early stage cancer 
using OCT. 
 
Fig. 6. SD-OCT images of in vivo oral dysplasia and normal tissues. (a) Dysplastic tissue 
before  application  of  dMNs  and  US,  (b)  dysplastic  tissue  after  both  dMNs  and  US  were 
applied, (c) normal tissue before dMNs and US were applied, (d) normal tissue after both 
dMNs  and  US  were  applied.  Yellow  areas  were  quantitatively  analyzed  for  OCT  signal 
intensity in Fig. 7. 
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Fig. 7. Depth-dependent SD-OCT signal intensity profiles in dysplastic and normal hamster 
cheek pouch tissues. Yellow area: stratum corneum (SC); green area: epithelial layer; blue area: 
disrupted epithelial layer in dysplastic tissue. 
The distinctive OCT images (Fig. 6) and signal intensity profiles (Fig. 7) in dysplasic and 
normal hamster cheek pouch tissues were compared with histological observations. As shown 
in Fig. 8, the epithelial layer in dysplastic tissue demonstrated disrupted stratification and 
epithelial thickening and downgrowth (yellow-dotted area). The appearance and morphology 
of the OCT image (Fig. 6b) and concurrent enhanced contrast of the deeper epithelial layers 
(Fig. 7a) paralleled the histological appearance of dysplasia (Fig. 8). 
 
Fig. 8. H&E stained dysplastic and normal hamster cheek pouch tissues. 
4. Conclusions 
In  order  to  enhance  optical  contrast  for  in  vivo  OCT  imaging  by  overcoming  structural 
barriers, such as the SC and mucosa, Au NPs were delivered in dMNs followed by a brief 
application of US. Considerably enhanced OCT images presenting clear structural differences 
between dysplastic and normal tissues were obtained. Quantitative analysis of OCT signal 
intensity  profiles  confirmed  increased  OCT  signal  intensity  in  the  SC  and  dramatically 
increased optical contrast in dysplastic epithelium after Au NP-containing dMNs and US were 
applied. The interpretation of contrast-enhanced OCT images and signal analysis paralleled 
histological data. Penetration depth and Au NP doses can be easily tuned by adjusting the 
length of the dMNs and Au NP loading ratio, respectively. Therefore, dMNs are a promising 
and  novel  platform  to  deliver  contrast  agents  across  biological  barriers  in  an  efficient, 
convenient, precisely controlled, and potentially cost-effective manner. 
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